NCT04045210

Brief Summary

The Researchers are trying to evaluate efficacy of a psychotherapeutic approach that can be applied to those who are critically ill. The daily approach in the Intensive Care Unit (ICU) is designed to provide patients with psychological support, reassurance, and explanations of where they are and what is happening to them.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
274

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 25, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 5, 2019

Completed
25 days until next milestone

Study Start

First participant enrolled

August 30, 2019

Completed
5.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 15, 2025

Completed
Last Updated

May 14, 2025

Status Verified

May 1, 2025

Enrollment Period

5.4 years

First QC Date

July 25, 2019

Last Update Submit

May 13, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • minimal important change in hospital anxiety and depression scale - Anxiety

    This outcome will be evaluated using Hospital Anxiety and Depression Scale (HADS). The total scores range is 0-21 for both depression and anxiety scores. A higher score indicates a worse depression and anxiety. Comparison will be done between the score obtained from the control group and the two intervention groups within 96 hours after ICU discharge and at 6 months follow up

    within 96 hours after ICU discharge and 3 months after hospital discharge

Secondary Outcomes (1)

  • minimal important change in hospital anxiety and depression scale-Depression

    within 96 hours after ICU discharge and 3 months after hospital discharge

Other Outcomes (3)

  • minimal important change in Impact of Event Scale-Revised

    within 96 hours after ICU discharge and 3 months after hospital discharge

  • statistically significant improvement in MoCA-blind

    within 96 hours after ICU discharge and 3 months after hospital discharge

  • EQ-5D-3L

    within 96 hours after ICU discharge and 3 months after hospital discharge

Study Arms (2)

No Intervention

NO INTERVENTION

Doula

EXPERIMENTAL
Other: Psychological Support Based on Positive Suggestions

Interventions

Eligible patients will be randomized at the earliest possible time after meeting inclusion criteria. Patients will be randomized 1:1 to intervention by ICU doulas or a non-intervention arms stratified by ICU location. Both intervention and controls will receive standard medical care at the discretion of the ICU team. The intervention arm will receive PSBPS as soon as feasible and continue on a daily basis. Doulas will also liaise with family, the team, and with the nursing staff. Both intervention and standard of care arms will complete follow-up questionnaires measuring symptoms of anxiety, depression, acute stress and cognitive function after ICU discharge and at 3 months follow up by phone. All the patients randomized to the intervention arm will receive the same intervention.

Doula

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Critically ill adult patients (age \>18) requiring non-invasive ventilation, high flow O2 or mechanical ventilation and expected to stay \>48 hours.

You may not qualify if:

  • history of dementia
  • intellectual disability
  • suicide attempt
  • psychotic disorders such as schizophrenia
  • acute alcohol/substance intoxication or withdrawal
  • severe metabolic encephalopathy
  • patients on comfort care
  • Patients not expected to survive the hospital stay
  • Non-English speaking.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This will be a tho arm single-center, prospective, randomized, controlled trial comparing the effect of PSBPS vs. no PSBPS on psychological and clinical outcomes in the critically ill population. PSBPS will be administered by trained ICU doulas to eligible patients
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 25, 2019

First Posted

August 5, 2019

Study Start

August 30, 2019

Primary Completion

January 31, 2025

Study Completion

March 15, 2025

Last Updated

May 14, 2025

Record last verified: 2025-05

Locations